Company logo

NMRD - Nemaura Medical Inc.

NASDAQ -> Healthcare -> Medical Devices
New York, United States
Type: Equity

NMRD price evolution
NMRD
(in millions $) 31 Jan 2023 30 Sep 2022 30 Jun 2022 31 Mar 2022
Current assets
Cash $10.11 $14.75 $17.75
Short term investments
Net receivables $0.38 $0.22 $0.1
Inventory $1.49 $1.91 $1.63 $1.49
Total current assets $20.09 $13.95 $17.7 $20.09
Long term investments
Property, plant & equipment $0.53 $0.52 $0.6 $0.53
Goodwill & intangible assets $1.43 $1.41 $1.48
Total noncurrent assets $1.95 $2.02 $2.01
Total investments
Total assets $22.1 $15.9 $19.72 $22.1
Current liabilities
Accounts payable $0.14 $0.42 $0.09 $0.14
Deferred revenue $1.03 $1.2 $1.31
Short long term debt $17.4 $16.19 $19.19
Total current liabilities $20.58 $20.47 $17.95 $20.58
Long term debt $3.49 $4.7
Total noncurrent liabilities $4.45 $5.72 $1.05
Total debt $20.89 $20.89 $19.19
Total liabilities $21.64 $24.91 $23.67 $21.64
Shareholders' equity
Retained earnings -$37.73 -$45.79 -$41.71 -$37.73
Other shareholder equity -$0.12 -$1.54 -$0.57 -$0.12
Total shareholder equity -$9.01 -$3.96 $0.47
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Current assets
Cash $17.75 $31.87 $0.11 $3.74
Short term investments
Net receivables $0.1 $0.38 $0.09 $0.1
Inventory $1.49 $0.85 $0.29 $0.04
Total current assets $20.09 $33.99 $0.84 $4.52
Long term investments
Property, plant & equipment $0.53 $0.2 $0.16 $0.06
Goodwill & intangible assets $1.48 $1.06 $0.21 $0.19
Total noncurrent assets $2.01 $1.26 $0.38 $0.25
Total investments
Total assets $22.1 $35.24 $1.22 $4.76
Current liabilities
Accounts payable $0.14 $0.25 $0.29 $0.16
Deferred revenue $1.31 $1.38 $1.24 $1.3
Short long term debt $19.19 $5.73
Total current liabilities $20.58 $6.42 $1.39 $1.3
Long term debt $19.19 $19.19
Total noncurrent liabilities $1.05 $20.46 $1.15 $1.24
Total debt $19.19 $24.92
Total liabilities $21.64 $26.88 $2.53 $2.54
Shareholders' equity
Retained earnings -$37.73 -$23.84 -$17.59 -$13.43
Other shareholder equity -$0.12 $0.14 -$0.34 -$0.34
Total shareholder equity $0.47 $8.36 -$1.31 $2.23
(in millions $) 31 Jan 2023 30 Sep 2022 30 Jun 2022 31 Mar 2022
Revenue
Total revenue $0.07 $0.32
Cost of revenue $0.07 $0.17
Gross Profit $0 $0.15
Operating activities
Research & development $0.26 $0.33 $0.57
Selling, general & administrative $2.32 $1.88 $2.02
Total operating expenses $2.58 $2.21 $2.59
Operating income -$2.58 -$2.21 -$2.44
Income from continuing operations
EBIT -$2.58 -$2.21 -$2.44
Income tax expense -$0.35
Interest expense $1.5 $1.77 $1.52
Net income
Net income -$4.08 -$3.98 -$3.62
Income (for common shares) -$4.08 -$3.98 -$3.62
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Revenue
Total revenue $0.5
Cost of revenue $0.34
Gross Profit $0.16
Operating activities
Research & development $1.56 $1.55 $2.01 $2.3
Selling, general & administrative $6.17 $3.03 $2.77 $2.18
Total operating expenses $7.73 $4.59 $4.78 $4.48
Operating income -$7.57 -$4.59 -$4.78 -$4.48
Income from continuing operations
EBIT -$7.57 -$4.59 -$4.77 -$4.45
Income tax expense -$0.35 -$0.34 -$0.61 -$0.61
Interest expense $6.67 $2.01
Net income
Net income -$13.89 -$6.26 -$4.16 -$4.45
Income (for common shares) -$13.89 -$6.26 -$4.16 -$4.45
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Net income -$4.08 -$3.98 -$3.62 -$3.43
Operating activities
Depreciation $0.07 $0.1 $0.09 $0.06
Business acquisitions & disposals
Stock-based compensation $0.22
Total cash flows from operations -$2.16 -$2.38 -$2.15 -$0.88
Investing activities
Capital expenditures -$0.16 -$0.22 -$0.08 -$0.19
Investments
Total cash flows from investing -$0.16 -$0.22 -$0.08 -$0.19
Financing activities
Dividends paid
Sale and purchase of stock $2.95 $0.11
Net borrowings -$1.5 -$0.07 -$5.9 -$2.7
Total cash flows from financing -$1.5 -$0.07 -$2.95 -$2.59
Effect of exchange rate -$0.81 -$0.32 -$0.12 -$0.07
Change in cash and equivalents -$4.96 -$2.68 -$5.17 -$3.66
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Net income -$13.89 -$6.26 -$4.16 -$4.45
Operating activities
Depreciation $0.23 $0.1 $0.05 $0.03
Business acquisitions & disposals
Stock-based compensation $0.22 $0.11 $0.57 $0.43
Total cash flows from operations -$6.5 -$6 -$3.45 -$3.56
Investing activities
Capital expenditures -$0.96 -$0.84 -$0.21 -$0.08
Investments $4.48
Total cash flows from investing -$0.96 -$0.84 -$0.21 $4.4
Financing activities
Dividends paid
Sale and purchase of stock $3.07 $14.79 $0.11 $2.47
Net borrowings -$12.4 $22.79 -$0.04
Total cash flows from financing -$6.37 $37.99 $0.1 $2.05
Effect of exchange rate -$0.29 $0.61 -$0.07 $0.03
Change in cash and equivalents -$13.83 $31.15 -$3.56 $2.89
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding N/A
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 46.42
Net debt/EBITDA N/A
Current ratio 0.98
Quick ratio 0.90